These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 8393579)
1. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Selwyn PA; Budner NS; Wasserman WC; Arno PS Public Health Rep; 1993; 108(4):492-500. PubMed ID: 8393579 [TBL] [Abstract][Full Text] [Related]
2. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742 [TBL] [Abstract][Full Text] [Related]
3. Population-based study of malignancies and HIV infection among injecting drug users in a New York City methadone treatment program, 1985-1991. Gachupin-Garcia A; Selwyn PA; Budner NS AIDS; 1992 Aug; 6(8):843-8. PubMed ID: 1329849 [TBL] [Abstract][Full Text] [Related]
4. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). Solomon L; Stein M; Flynn C; Schuman P; Schoenbaum E; Moore J; Holmberg S; Graham NM J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):253-61. PubMed ID: 9495226 [TBL] [Abstract][Full Text] [Related]
5. On-site medical care in methadone maintenance: associations with health care use and expenditures. Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723 [TBL] [Abstract][Full Text] [Related]
6. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH N Engl J Med; 1989 Mar; 320(9):545-50. PubMed ID: 2915665 [TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411 [TBL] [Abstract][Full Text] [Related]
8. No seroconversions among steady sex partners of methadone-maintained HIV-1-seropositive injecting drug users in New York City. Siddiqui NS; Brown LS; Phillips RY; Vargas O; Makuch RW AIDS; 1992 Dec; 6(12):1529-33. PubMed ID: 1492936 [TBL] [Abstract][Full Text] [Related]
9. A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients. Silberstein CH; O'Dowd MA; Chartock P; Schoenbaum EE; Friedland G; Hartel D; McKegney FP Gen Hosp Psychiatry; 1993 Nov; 15(6):351-9. PubMed ID: 8112557 [TBL] [Abstract][Full Text] [Related]
10. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072 [TBL] [Abstract][Full Text] [Related]
11. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. Selwyn PA; Schoenbaum EE; Davenny K; Robertson VJ; Feingold AR; Shulman JF; Mayers MM; Klein RS; Friedland GH; Rogers MF JAMA; 1989 Mar; 261(9):1289-94. PubMed ID: 2915455 [TBL] [Abstract][Full Text] [Related]
12. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Caiaffa WT; Vlahov D; Graham NM; Astemborski J; Solomon L; Nelson KE; Muñoz A Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1493-8. PubMed ID: 7952605 [TBL] [Abstract][Full Text] [Related]
13. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. Phair J; Muñoz A; Detels R; Kaslow R; Rinaldo C; Saah A N Engl J Med; 1990 Jan; 322(3):161-5. PubMed ID: 1967190 [TBL] [Abstract][Full Text] [Related]
14. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. Hirschtick RE; Glassroth J; Jordan MC; Wilcosky TC; Wallace JM; Kvale PA; Markowitz N; Rosen MJ; Mangura BT; Hopewell PC N Engl J Med; 1995 Sep; 333(13):845-51. PubMed ID: 7651475 [TBL] [Abstract][Full Text] [Related]
15. Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Gourevitch MN; Selwyn PA; Davenny K; Buono D; Schoenbaum EE; Klein RS; Friedland GH Ann Intern Med; 1993 Mar; 118(5):350-5. PubMed ID: 8094280 [TBL] [Abstract][Full Text] [Related]
16. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost. Avants SK; Margolin A; Sindelar JL; Rounsaville BJ; Schottenfeld R; Stine S; Cooney NL; Rosenheck RA; Li SH; Kosten TR Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294 [TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus infection in women infected with the human immunodeficiency virus. Sun XW; Kuhn L; Ellerbrock TV; Chiasson MA; Bush TJ; Wright TC N Engl J Med; 1997 Nov; 337(19):1343-9. PubMed ID: 9358128 [TBL] [Abstract][Full Text] [Related]
18. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. Wallace JM; Hansen NI; Lavange L; Glassroth J; Browdy BL; Rosen MJ; Kvale PA; Mangura BT; Reichman LB; Hopewell PC Am J Respir Crit Care Med; 1997 Jan; 155(1):72-80. PubMed ID: 9001292 [TBL] [Abstract][Full Text] [Related]
19. Respiratory illness in persons with human immunodeficiency virus infection. The Pulmonary Complications of HIV Infection Study Group. Wallace JM; Rao AV; Glassroth J; Hansen NI; Rosen MJ; Arakaki C; Kvale PA; Reichman LB; Hopewell PC Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1523-9. PubMed ID: 8256894 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]